{
    "root": "3531e516-f3e9-02e7-e063-6294a90a7846",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Rosuvastatin Calcium",
    "value": "20250515",
    "ingredients": [
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "2S7830E561"
        },
        {
            "name": "HYPROMELLOSE 2208 (100 MPA.S)",
            "code": "B1QE5P712K"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "ROSUVASTATIN CALCIUM",
            "code": "83MVU38M7Q"
        }
    ],
    "indications": "Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.",
    "contraindications": "• Rosuvastatin calcium tablets can be taken with or without food, at any time of day. ( 2.1 ) • Dose range: 5-40 mg once daily. Use 40 mg dose only for patients not reaching LDL-C goal with 20 mg. ( 2.1 ) • Adult HoFH: Starting dose 20 mg/day ( 2.1 )",
    "warningsAndPrecautions": "Rosuvastatin calcium tablets are supplied as:\n                  \n                  \n                     10 mg: ﻿Yellow, round, biconvex, coated tablets. Debossed as ‘CY’ on one side, and ‘10’ on other side.\n \n                  \n                     NDC 71335-9640-1: 30 Tablets in a BOTTLE\n                     NDC 71335-9640-2: 90 Tablets in a BOTTLE\n                     NDC 71335-9640-3: 60 Tablets in a BOTTLE\n                     NDC 71335-9640-4: 120 Tablets in a BOTTLE\n                     NDC 71335-9640-5: 180 Tablets in a BOTTLE\n                     NDC 71335-9640-6: 100 Tablets in a BOTTLE\n                  \n                  \n                     Storage\n                  \n                  Store at controlled room temperature, 20ºC to 25ºC (68ºF to 77ºF); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP\n                  Controlled Room Temperature]. Protect from moisture.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions": "Rosuvastatin is contraindicated in the following conditions:\n                  •           Patients with a known hypersensitivity to any component of this product. Hypersensitivity reactions including rash, pruritus, urticaria, and angioedema have been reported with rosuvastatin\n \n  [see\n  \n   Adverse Reactions (6.1)]\n \n  .\n\n \n                  •           Patients with active liver disease, which may include unexplained persistent elevations of hepatic transaminase levels\n \n  [see\n  \n   Warnings and Precautions (5.3)]\n \n  .\n\n \n                  •           Pregnancy\n \n  [see\n  \n   Use in Specific Populations (\n  \n   8.1,\n  \n   8.3)]\n \n  .\n\n \n                  •           Lactation. Limited data indicate that rosuvastatin is present in human milk. Because statins have the potential for serious adverse reactions in nursing infants, women who require rosuvastatin treatment should not breastfeed their infants\n \n  [see\n  \n   Use in Specific Populations (8.2)]\n \n  ."
}